SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Mac who wrote (634)7/16/1998 11:31:00 AM
From: admr  Read Replies (1) of 1754
 
I read your post. Going forward visx will do well with incresaing
nearsighted patients using th excimer laser. However, the use of the excimer laser in hyperopia, presbyopia is a difficult procedure,
invasive and not without complications. The Sunrise Tech Laser using LTK Holmium laser will be the laser of choice for the above indications. It is much easier to use, less complications.
I believe they are submitting to the FDA in October with approval in 1999. The excimer will get approval this year but for hyperopia,
presbopia and overcorrection resulting from PRK and Lasik treatments for myopia its clear that the Sunrise Laser will be used. The excimer will be for these indications be obsolete in six months.

Andrew Richman M.D,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext